BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28

• 

  Drug Development

  Why ImmunoGen Investors are Waiting on Bated Breath to Move “FORWARD”

  February 22, 2017

   · 

  2 min read
• 

  Policy

  Pfizer, Celgene, Eli Lilly, Merck & Co. CEOs and Other Execs Send Letter Supporting GOP Tax Plan

  February 22, 2017

   · 

  2 min read
• Policy

  A Call For The FDA To Raise The Bar For Clinical Trials Is Flawed

  February 22, 2017

   · 

  1 min read
• 

  Business

  Why This UC Berkeley Scientist is Planning to Take on Washington in 2018

  February 22, 2017

   · 

  3 min read
• This Marijuana Stock Is Already Worth $3 Billion—Is It a Buy?

  February 22, 2017

   · 

  1 min read
• This, And Not The Brain, Is What Decides Whether You’ll Be Left Or Right Handed, Ruhr-University Reveals

  February 22, 2017

   · 

  1 min read
• 

  BioMidwest

  These Are the 4 Most Admired Life Science Companies in the World

  February 22, 2017

   · 

  3 min read
• 

  Policy

  North Korean Biotech Institute Allegedly Involved in the Killing of Leader Kim Jong-Un’s Half Brother

  February 22, 2017

   · 

  2 min read
• 

  Business

  Why This 11-Employee Massachusetts Biotech’s Market Cap Doubled Yesterday

  February 22, 2017

   · 

  2 min read
• 

  Genetown

  FDA Approval of Siliq for Psoriasis—How Will the Drug Perform in an Already Overcrowded Market?

  February 22, 2017

   · 

  2 min read